date:Aug 28, 2012
Dietetic Products, Nutrition and Allergies (NDA) that only trials of four weeks or longer were sufficient in the gastro area.
The NDA said four weeks was needed due to the,fluctuating nature of gastro-intestinal symptomsand dismissed a two-week trial Clasado had submitted under the EU nutrition and health claims regulation (NHCR).
EFSA considers that it is the responsibility of the applicant to ensure that the studies are performed according standards that are generally accepted by experts in